AbbVie Inc (N:ABBV)

INK Ultra Money Free

INK Ultra Money Premium
Latest 10 SEC filings (by transaction date) for ABBV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 24th, 2020
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction Volume or Value Price
Jan 6/20 Jan 2/20 Donoghoe Nicholas Direct Ownership Common stock, $0.01 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -902 $88.54
Jan 3/20 Dec 31/19 Alpern Robert J Direct Ownership Stock Equivalent Unites A - Grant, award or other under Rule 16b-3(d) 77 $88.54
Jan 3/20 Dec 31/19 Liddy Edward M Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 367 $88.54
Jan 3/20 Dec 31/19 Rapp Edward J Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 384 $88.54
Dec 12/19 Dec 10/19 Stewart Jeffrey Ryan Direct Ownership Common Stock, $0.01 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,713 $86.44
Dec 13/19 Dec 4/19 Gonzalez Richard A Direct Ownership Common stock, $0.01 par value G - Gift -4,000  
Nov 8/19 Nov 4/19 Schumacher Laura J Direct Ownership Common Stock, $0.01 par value G - Gift -358  
Oct 1/19 Sep 30/19 Rapp Edward J Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 449 $75.72
Oct 1/19 Sep 30/19 Liddy Edward M Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 429 $75.72
Oct 1/19 Sep 30/19 Alpern Robert J Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 90 $75.72
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ABBV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 24th, 2020
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction Volume or Value Price
Jan 6/20 Jan 2/20 Donoghoe Nicholas Direct Ownership Common stock, $0.01 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -902 $88.54
Jan 3/20 Dec 31/19 Alpern Robert J Direct Ownership Stock Equivalent Unites A - Grant, award or other under Rule 16b-3(d) 77 $88.54
Jan 3/20 Dec 31/19 Liddy Edward M Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 367 $88.54
Jan 3/20 Dec 31/19 Rapp Edward J Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 384 $88.54
Dec 13/19 Dec 4/19 Gonzalez Richard A Direct Ownership Common stock, $0.01 par value G - Gift -4,000  
Dec 12/19 Dec 10/19 Stewart Jeffrey Ryan Direct Ownership Common Stock, $0.01 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,713 $86.44
Nov 8/19 Nov 4/19 Schumacher Laura J Direct Ownership Common Stock, $0.01 par value G - Gift -358  
Oct 1/19 Sep 30/19 Rapp Edward J Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 449 $75.72
Oct 1/19 Sep 27/19 Richmond Timothy J. Direct Ownership Common stock, $0.01 par value S - Open market or private sale -15,515 $75.02
Oct 1/19 Sep 30/19 Liddy Edward M Direct Ownership Stock Equivalent Units A - Grant, award or other under Rule 16b-3(d) 429 $75.72
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ABBV

View on Twitter

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
Arvinas (OQ:ARVN)
Merck & Co. (N:MRK)